Delivery Order SPE2DX22D0079-SPE2D825FAEE5
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $300,974.60 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents a child action under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $110,752.60 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is performed at the vendor's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,068.48 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $35,917.58 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is performed at the contractor's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $73,804.12 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,532.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 30, 2025, with a ceiling value of $47,036.73. This firm fixed-price delivery order, which closes on July 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $13,364.95 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which received no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical. The contract's place...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,367.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $170,839.58 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- SPE2DX22D0079Indefinite Delivery Contract
- SPE2DX22D0079-SPE2D825FAEE5Delivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $333,424.54 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 30, 2025, with an ultimate completion date of July 1, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical supply needs for federal military and veteran healthcare systems through this vehicle. As a pharmaceutical prime vendor, AmerisourceBergen supplies a comprehensive range of medical commodities under the DLA contract, including brand-name and generic medications, specialty pharmaceuticals, vaccines, medical devices, syringes, vials, and diagnostic test kits across multiple therapeutic domains. The company's delivery orders under this IDC vehicle demonstrate its capability to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with flexible, competitively awarded supply solutions. The DLA Troop Support Medical program represents a strategic approach to global pharmaceutical support for military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $333.4k | 6/30/25 |